1 asset in Pseudohypoparathyroidism Type 1A
Therapeutic assets addressing Pseudohypoparathyroidism Type 1A, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Setmelanotide Pseudohypoparathyroidism Type 1A | Massachusetts General Hospital | P2 | CCC (53) |